First Light Asset Management »

Anaptysbio Inc Common shares owned by First Light Asset Management

Quarter-by-quarter ownership of Anaptysbio Inc Common (ANAB) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Anaptysbio Inc Common

Tip: Access up to 7 years of quarterly data

All positions including Anaptysbio Inc Common held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anaptysbio Inc Common by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $27M 1.2M 21.42
2023-09-30 $14M 791k 17.96
2023-06-30 $6.6M 322k 20.34

More positions owned by First Light Asset Management

Karuna Therapeutics Common Stocks
Alphatec Holdings Common Stocks (ATEC)
Xenon Pharmaceuticals Common Stocks (XENE)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Pliant Therapeutics Common Stocks (PLRX)
Neogenomics Common Stocks (NEO)
Transmedics Group Common Stocks (TMDX)
Si-bone Common Stocks (SIBN)
Atricure Common Stocks (ATRC)
Paragon 28 Common Stocks (FNA)
Model N Common Stocks (MODN)
Tactile Systems Technology Common Stocks (TCMD)
Prothena Corporation Common Stocks (PRTA)
Ultragenyx Pharmaceutical Common Stocks (RARE)
Performant Financial Corporation Common Stocks (PFMT)

View all positions for First Light Asset Management

Top funds holding Anaptysbio Inc Common

EcoR1 Capital
Tang Capital Management
Vanguard Group
Boxer Capital
First Light Asset Management
Dr. Jeffrey R. Jay, M.D.
Frazier Life Sciences Management
Point72 Asset Management
Palo Alto Investors
Dimensional Fund Advisors
Eventide Asset Management
Millennium Management
Franklin Resources
5AM Venture Management
Blackstone Group

View all funds holding Anaptysbio Inc Common